Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00964314
Other study ID # WJB720603
Secondary ID
Status Completed
Phase N/A
First received August 19, 2009
Last updated April 19, 2012
Start date February 2009
Est. completion date October 2011

Study information

Verified date April 2012
Source Ministry of Science and Technology of the People´s Republic of China
Contact n/a
Is FDA regulated No
Health authority China: Ethics Committee
Study type Interventional

Clinical Trial Summary

The study objective is to evaluate the effectiveness of Traditional Chinese Medicine (TCM) five elements music therapy improving quality of life for patients with advanced cancer, as well as establishing the standard operating procedures (SOP) for it.


Description:

Design: As randomized controlled trial (RCT) with un-blinded design will be done.


Recruitment information / eligibility

Status Completed
Enrollment 146
Est. completion date October 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Eligible participation will be enrolled based on diagnostic criteria.

- Advanced cancer patient with more than 50 scores of Karnofsky Performance Score (KPS).

- Diagnosis of advanced cancer

- Patients who are willing to be subject with taking part in this research voluntarily.

- No prior experience with TCM music therapy.

- Newly admitted to TCM oncology department for 3 weeks treatment course.

Exclusion Criteria:

- Complicated diagnose or one who don't consistent with inclusion criteria.

- Patients suffering from psychosis or diagnosis, or psychiatric diagnoses (e.g., schizophrenia).

- Suffering from acute organ prostration or other condition of demanding to rescue,inability for accepting music therapy.

- One don't read or fill in diary owing to some causes, such as state of the art or acuity of vision

- One suffering from hearing disturbance

- Accepted TCM five elements music therapy in the past.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
music
Experimental Group one : Listening TCM five elements music therapy(TCMMT)based on conventional therapy in China. Experimental Group two: Listening western music based on conventional therapy in China. Control Group: no music therapy will be done.

Locations

Country Name City State
China Oncology Department of Xi Yuan hospital Beijing HaiDian district
China Xi-Yuan Hospital, China Academy of Chinese Medical Sciences Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Ministry of Science and Technology of the People´s Republic of China M.D. Anderson Cancer Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of KPS Qol, and Diary at baseline and endpoint in each group (data for < 70 year old group). Comparison of Qol, KPS, Diary at baseline and endpoint, the result shown here were significantly different for all terms in TCM five elements music group, p=0. p=0.0015, p=0.0015 respectively. However, no significant difference was seen for all terms in Western music group and the no music group respectively (See Table 3). Difference of(pro-post)treatment for KPS,Qol, Diary Yes
Primary Comparison of KPS Qol, and Diary at baseline and endpoint in each group (data for the >70 year old group). Comparison of Qol, KPS and Diary score at baseline and endpoint results show there was a significant difference for the QoL in TCM five elements music group, p value is 0.0062. However, there was no significant difference for the KPS and Diary score in each group respectively(See Table 4). Difference of(pro-post)treatment for KPS,Qol, Diary Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links